Consolidated Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7270714

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
17,951,000,000 JPY
25,986,000,000 JPY
Interest and dividends received
801,000,000 JPY
754,000,000 JPY
Income taxes paid
-7,471,000,000 JPY
-8,358,000,000 JPY
Interest paid
-34,000,000 JPY
-22,000,000 JPY
Net cash provided by (used in) operating activities
11,246,000,000 JPY
18,360,000,000 JPY
Cash flows from investing activities
Purchase of securities
-2,000,000,000 JPY
-4,000,000,000 JPY
Purchase of property, plant and equipment
-26,056,000,000 JPY
-12,756,000,000 JPY
Proceeds from sale of property, plant and equipment
22,000,000 JPY
5,000,000 JPY
Net cash provided by (used in) investing activities
-18,415,000,000 JPY
-19,576,000,000 JPY
Purchase of investment securities
-18,000,000 JPY
-220,000,000 JPY
Proceeds from sale of investment securities
959,000,000 JPY
531,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-11,176,000,000 JPY
Other, net
138,000,000 JPY
-231,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
-12,000,000,000 JPY
Dividends paid
-7,505,000,000 JPY
-7,223,000,000 JPY
Net cash provided by (used in) financing activities
-7,768,000,000 JPY
-19,463,000,000 JPY
Other, net
-262,000,000 JPY
-239,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,220,000,000 JPY
890,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-13,717,000,000 JPY
-19,789,000,000 JPY
Cash and cash equivalents
45,973,000,000 JPY
59,690,000,000 JPY
79,480,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.